2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Mixed Oligoastrocytoma: new trials by email Literature Review of Mixed Oligoastrocytoma trials Research Report on Mixed Oligoastrocytoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma IL13-PE38QQR, targeted fusion protein therapy, surgery - Malignant Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | Completed | INSYS Therapeutics Inc | 80 | 2002-07-01 | 2011-06-06 |
| Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma IL13-PE38QQR, targeted fusion protein therapy, surgery - Malignant Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | Completed | INSYS Therapeutics Inc | 60 | 2000-11-01 | 2014-11-14 |
Astrocytoma (2) · Glioblastoma (2) · Glioma (2) · Neoplasms (1) · Recurrence (1)
Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2) · Disease Attributes (1) · Neoplasms (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
IL13-PE38 (2) · Surgical Procedures, Operative (2)
United States (2) · Germany (1) · Israel (1)
Jon Weingart, MD (1)